Viking Therapeutics, Inc. - Common Stock — Quarterly Financial Statistics (NASDAQ:VKTX) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -52.33 M-47.06 M-94 M-85.29 M-113.98 M -340.33 M Cash from investing activities 63.24 M42.51 M160.03 M75.61 M54.19 M 332.33 M Cash from financing activities 349 K507 K480 K75.1 M12.08 M 88.17 M Free cash flow -52.33 M-47.06 M-94 M-85.29 M-113.98 M -340.33 M

News

Viking Therapeutics, Inc. (VKTX) Stock Falls Amid Market Uptick: What Investors Need to Know

Viking Therapeutics: Still Cheap, But Watch Double Top (NASDAQ:VKTX)

NVO Rallies 11% in a Month: How Should Investors Play the Stock?

Buyout Buzz Around VKTX Is Back: What's Fueling the Speculation?

Novo Nordisk's Wegovy Pill Escalates Eli Lilly Rivalry (NYSE:NVO)

Why Viking Therapeutics, Inc. (VKTX) Dipped More Than Broader Market Today

LLY Hits Another Record High: Is the Stock Too Expensive to Buy Now?

Eli Lilly's Market Cap Balloons Again On This IPO's Setback

Can Medicare Bridge Help Novo Nordisk Defend Its GLP-1 Leadership?

Lilly Up Around 7% in a Week: Should You Buy, Sell or Hold the Stock?

Viking Therapeutics, Inc. (VKTX) Sees a More Significant Dip Than Broader Market: Some Facts to Know

Can Eli Lilly's New Drugs Fuel Growth Beyond Its GLP-1 Blockbusters?